MedPath

SUBclavian Central Venous Catheters Guidance and Examination by UltraSound

Phase 2
Completed
Conditions
Requiring Subclavian Vein Cannulation
Patient Covered by French Health Care System
Adult Patients
Interventions
Other: Ultrasound-guided cannulation and examination
Registration Number
NCT01888094
Lead Sponsor
University Hospital, Clermont-Ferrand
Brief Summary

Prospective, randomized controlled clinical unicentric study, in ICU, Cannulation of the subclavian venous and examination guided with ultrasound

Detailed Description

One groupe : Ultrasound guided for cannulation and examination of absence ofcomplications One groupe : landmark method and examination with chest radiography

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria
  • adults patients
  • requiring subclavian vein cannulation
  • patient covered by french health care system
Exclusion Criteria
  • patient refusal
  • requiring vein cannulation femoral or jugular
  • we see nothing with echocardiography
  • children and not adult patients

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
landmark method and examination with chest radiographyUltrasound-guided cannulation and examinationProspective, randomized controlled clinical unicentric study, in ICU, Cannulation of the subclavian venous and examination guided with ultrasound
ultrasound guided for cannulation and examinationUltrasound-guided cannulation and examinationProspective, randomized controlled clinical unicentric study, in ICU, Cannulation of the subclavian venous and examination guided with ultrasound
Primary Outcome Measures
NameTimeMethod
procedure time between the beginning of procedure ( TO) and when the catheter is controlled ( T4) between strategy catheter cannulation 'standard' and a strategy called "ultrasound allat day 1
Secondary Outcome Measures
NameTimeMethod
incidence of occurrence of complications: pneumothorax, hemothorax, bad positioning (outside of the superior vena cava or the right atrium) between the two strategiesat day 1
failure of technology between the two strategies.at day 1
occurrence of central venous catheter infection.at day 1
procedure time Tn-Tn (n 0-5) between the two strategies.at day 1

Trial Locations

Locations (1)

CHU Clermont-Ferrand

🇫🇷

Clermont-Ferrand, France

© Copyright 2025. All Rights Reserved by MedPath